NCT05432921 (EvOCaReAustria) is a clinical trial of Lifestyle modification in Cardiovascular Diseases, sponsored by Prof. Josef Niebauer M.D., Ph.D., MBA.

Who is sponsoring NCT05432921?

NCT05432921 is sponsored by Prof. Josef Niebauer M.D., Ph.D., MBA.

What drugs are being tested in NCT05432921?

Interventions in NCT05432921: Lifestyle modification.

What condition does NCT05432921 study?

NCT05432921 studies Cardiovascular Diseases.

Is NCT05432921 still recruiting?

NCT05432921 is currently status unknown. Last updated 13 April 2023.

Last reviewed 2023-04-13 · How we verify

NCT05432921: EvOCaReAustria

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cardiac Rehabilitation in Austrian Outpatient Facilities.

Status unknown Last updated 13 April 2023

What this trial tests

trial testing Lifestyle modification in Cardiovascular Diseases in 1,500 participants. Status unknown.

Timeline

27 September 2022

Primary endpoint
1 August 2023

31 December 2023

Quick facts

Lead sponsor	Prof. Josef Niebauer M.D., Ph.D., MBA
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,500
Start date	27 September 2022
Primary completion	1 August 2023
Estimated completion	31 December 2023
Sites	1 location across Austria

Drugs / interventions tested

Lifestyle modification

Conditions studied

Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

Prof. Josef Niebauer M.D., Ph.D., MBA

Who can join

18 and older, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiac rehabilitation (CR) is a key component of the treatment of cardiac diseases. The Austrian outpatient CR model is unique, as it provides patients with an extended professionally supervised, multidisciplinary program of 4-6 weeks of phase II (OUT-II) and 12 months of phase III (OUT-III) CR CR including a "refresher". The aim of this retrospective analysis is to pool data from preferably all Austrian outpatient rehabilitation facilities and to analyze the efficacy of the Austrian cardiac rehabilitation model with a special focus on phase III. Data of patients who completed OUT-III between 1.1.2019 and 01.07.2022 will be analyzed. All patients undergo assessment of anthropometry, resting blood pressure, lipid profile, fasting blood glucose, exercise capacity, quality of life, anxiety and depression at the beginning (T1), in the middle (T2) and end of CR (T3).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lifestyle modification

Trials testing the same drug.

NCT07533500 — Effect of Autogenic Relaxation Training on Irritable Bowel Syndrome In Adult Females · NA · not yet recruiting
NCT07462078 — The Effect of Lifestyle Modification on the Risk of Prediabetes Among Patients Attending Outpatient Clinic. · Phase 4 · completed
NCT06889454 — Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS · recruiting
NCT06690723 — Vitamin D and SGLT-2 Inhibitor in CPAP-naive Obstructive Sleep Apnea · Phase 3 · completed
NCT05086679 — Compression Stockings for Treating Vasovagal Syncope Trial · NA · unknown

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05432921 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prof. Josef Niebauer M.D., Ph.D., MBA
Last refreshed: 13 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05432921.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing